Evidence map›Paper›PMID 32565870›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Inhibitory Activity of

Aziiz Mardanarian Rosdianto, Irma Melyani Puspitasari, Ronny Lesmana, Jutti Levita

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Potential Cutaneous Applications ofInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Journal of experimental pharmacology · 2025
    Article
  5. Review
  6. Heliyon · 2024
    Article
  7. Article
  8. Antioxidants (Basel, Switzerland) · 2024
    Article
  9. Nephroprotective Activity ofDrug design, development and therapy · 2024
    Article
  10. The Nephroprotective Activity ofJournal of experimental pharmacology · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aziiz Mardanarian RosdiantoDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Irma Melyani PuspitasariDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.ORCID https://orcid.org/0000-0002-8515-7335
Ronny LesmanaPhysiology Molecular Laboratory, Central Laboratory, Universitas Padjadjaran, Sumedang 45363, Indonesia.ORCID https://orcid.org/0000-0002-7425-915X
Jutti LevitaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.ORCID https://orcid.org/0000-0002-4578-4174
Padjadjaran University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MATERIALS AND

methodsForty-eight male Wistar rats were divided into anti-inflammatory mechanism study (

resultsBREE reduces the infiltration of inflammatory cells in both the stomach and the intestine of acetic acid-induced rats. BREE also alters the expression of Akt and NF-kappaB p65 in the rat's stomach and intestine (

conclusionTaken together, BREE could inhibit the expression of Akt and NF-kappaB p65 in the stomach and intestine of acetic acid-induced Wistar rats. This plant could be further explored for its potential as plant-based antistomach ulceration.

Identifiers

PMID32565870
PMCPMC7256739
OpenAlexW3026820042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.